The antiplasmodial activity of norcantharidin analogs

USDA, ARS, Natural Products Utilization Research Unit, University, MS 38677, USA.
Bioorganic & medicinal chemistry letters (Impact Factor: 2.42). 09/2010; 20(22):6688-95. DOI: 10.1016/j.bmcl.2010.09.004
Source: PubMed


The antiplasmodial activities of sixty norcantharidin analogs were tested in vitro against a chloroquine sensitive (D6, Sierra Leone) and chloroquine resistant (W2) strains of Plasmodium falciparum. Forty analogs returned IC(50) values <500 μM against at least one of the P. falciparum strains examined. The ring open compound 24 ((1S,4R)-3-(allylcarbamoyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid) is the most active aliphatic analog (D6 IC(50)=3.0±0.0 and W2 IC(50)=3.0±0.8 μM) with a 20-fold enhancement relative to norcantharidin. Surprisingly, seven norcantharimides also displayed good antiplasmodial activity with the most potent, 5 returning D6=8.9±0.9 and W2 IC(50)=12.5±2.2 μM, representing a fivefold enhancement over norcantharidin.

Download full-text


Available from: Rajnish Sahu, Oct 01, 2014
  • Source
    • "The anticancer properties of cantharidin result in arrest of the cell cycle in G2/M phase, apoptosis, and oxygen radical damage to DNA [79]. However, the potential of this small molecule and its derivatives in medicine is not confined to their anticancer properties as they have also been reported to have activity against parasites such as Plasmodium falciparum and Leishmania major [80, 81]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Except for honey as food, and silk for clothing and pollination of plants, people give little thought to the benefits of insects in their lives. This overview briefly describes significant recent advances in developing insect natural products as potential new medicinal drugs. This is an exciting and rapidly expanding new field since insects are hugely variable and have utilised an enormous range of natural products to survive environmental perturbations for 100s of millions of years. There is thus a treasure chest of untapped resources waiting to be discovered. Insects products, such as silk and honey, have already been utilised for thousands of years, and extracts of insects have been produced for use in Folk Medicine around the world, but only with the development of modern molecular and biochemical techniques has it become feasible to manipulate and bioengineer insect natural products into modern medicines. Utilising knowledge gleaned from Insect Folk Medicines, this review describes modern research into bioengineering honey and venom from bees, silk, cantharidin, antimicrobial peptides, and maggot secretions and anticoagulants from blood-sucking insects into medicines. Problems and solutions encountered in these endeavours are described and indicate that the future is bright for new insect derived pharmaceuticals treatments and medicines.
    Evidence-based Complementary and Alternative Medicine 05/2014; 2014(2):904958. DOI:10.1155/2014/904958 · 1.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acid-ester and acid-amide norcantharidin derivatives are prepared using a 'one-pot' synthetic procedure utilizing the ThalesNano H-cube™ flow hydrogenator. Traditionally, rapid library generation and reaction scale up of these analogues was limited by the batch wise hydrogenation of 5,6-dehydronorcantharidin. This was resolved with the use of flow chemistry. With no associated scale up issues, a method was devised to produce norcantharidin, along with acid-ester and acid-amide analogues on any scale necessary for biological screening.
    Letters in Drug Design &amp Discovery 07/2011; 8(6):568-574. DOI:10.2174/157018011795906730 · 0.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This review summarizes the progress that has been made recently in the medicinal chemistry of cantharidin, a potent antitumor agent from traditional Chinese medicine. Thousands of analogues have been synthesized on the basis of cantharidin, a part of which show excellent properties, in particular, norcantharidin and norcantharimide. Despite the enormous effort made, the intriguing bioactivities, mechanism, indications, and their interplay are still ill-defined. This review provides our up-to-date understanding in connection with the therapeutic use, mechanism, structure-activity relationship (SAR) and interesting properties of cantharidin analogues. Considerable development in the design of cantharidin analogues, in combination with mechanistic studies, has laid a foundation for transforming novel antitumor drugs into the clinic.
    Current Medicinal Chemistry 11/2012; 20(2). DOI:10.2174/0929867311320020001 · 3.85 Impact Factor
Show more